Cancer Treatment Centers of America® (CTCA) at Western Regional Medical Center (Western) in Goodyear announced it will launch 12 additional industry-sponsored clinical trials from now through December 2014. New trials will include both Phases I and II studies seeking to provide treatment options for multiple cancer types, including pancreatic, lung, prostate, colorectal and bladder.
“These research studies further our mission at CTCA® to improve overall cancer care, providing additional, innovative treatment options for our patients,” said Glen Weiss, Director of Clinical Research and Medical Oncologist, CTCA at Western.
The additional 12 trials will bring the number of open trials to 54 from 42. Patient enrollment in treatment trials has increased by more than 550 percent since the clinical research program’s inception in 2012, with Western’s clinical research team treating more than 100 patients on clinical trials involving novel treatments. This year Western exceeds the national average for adult patients participating on research studies by more than 300 percent. The breadth of research includes participation from the majority of Western’s medical oncologists who are committed to opening trials as quickly as possible.
“We truly value a patient’s immediate need for treatment options and do our best to ensure trials are fully operational in a matter of weeks versus months,” added Weiss.
For more information on the CTCA clinical trials program as well as trials currently open, visit http://www.cancercenter.com/clinical-trials/.
